The evaluation of p16 and ki67 immunoexpression in ameloblastomas

Romanian Journal of Morphology and Embryology

Volumn 55, Issue 2, 2014, Pages 363-367

  Alin Olimid, Daniel ^a   Florescu, Alma Maria ^b   Cernea, Daniela ^b   Georgescu, Corneliu Cristian ^b   Mǎrgǎritescu, Claudiu ^b   Simionescu, Cristiana Eugenia ^b   Stepan, Alex Emilian ^b  

^a UNIVERSITY OF CRAIOVA   (Romania)

^b UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

Ameloblastoma; Ki67; P16

Indexed keywords

KI 67 ANTIGEN; P16 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; AMELOBLASTOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; JAW TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AMELOBLASTOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JAW NEOPLASMS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM PROTEINS;

EID: 84903146606     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kramer IRH, Pindborg JJ, Shear M (eds), Histological typing of odontogenic tumours, World Health Organization International Histological Classification of Tumours, 2nd edition, Springer-Verlag, Berlin-Heidelberg, 1992.
2. Sheppard BC, Temeck BK, Taubenberger JK, Pass HI, Pulmonary metastatic disease in ameloblastoma, Chest, 1993, 104(6):1933-1955.
3. Laxmidevi BL, Kokila G, Jyothi M, Ameloblastoma -adding perspectives, J Dent Sci Res, 2010, 1(2):11-22.
4. Robinson L, Martinez MG, Unicystic ameloblastoma: a prognostically distinct entity, Cancer, 1977, 40(5):2278-2285.
5. Vohra FA, Hussain M, Mudassir MS, Ameloblastomas and their management: a review, J Surg Pak (Int), 2009, 14(3): 136-142.
6. Funaoka K, Arisue M, Kobayashi I, Iizuka T, Kohgo T, Amemiya A, Totsuka Y, Immunohistochemical detection of proliferating cell nuclear antigen (PCNA) in 23 cases of ameloblastoma, Eur J Cancer B Oral Oncol, 1996, 32B(5): 328-332.
7. Sandra F, Mitsuyasu T, Nakamura N, Shiratsuchi Y, Ohishi M, Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma, Oral Oncol, 2001, 37(2):193-198.
8. Liu J, Wang S, Chen X, Li Y, Proliferating activity and differentiation between peripheral cells and central cells in ameloblastoma, Zhonghua Kou Qiang Yi Xue Za Zhi, 2002, 37(1):62-64.
9. Bello IO, Tight junction proteins and cancer-associated fibroblasts in ameloblastoma, ameloblastic carcinoma and mobile tongue cancer, Acta Universitatis Ouluensis D Medica, 2010, 1040.
10. Barboza CA, Pereira Pinto L, Freitas Rde A, Costa Ade L, Souza LB, Proliferating cell nuclear antigen (PCNA) and p53 protein expression in ameloblastoma and adenomatoid odontogenic tumor, Braz Dent J, 2005, 16(1):56-61.
11. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA, Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers, Nature, 1994, 368(6473):753-756.
12. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G, Kamb A, Complex structure and regulation of the P16 (MTS1) locus, Cancer Res, 1995, 55(14):2988-2994.
13. Nguyen C, Liang G, Nguyen TT, Tsao-Wei D, Groshen S, Lübbert M, Zhou JH, Benedict WF, Jones PA, Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells, J Natl Cancer Inst, 2001, 93(19):1465-1472.
14. Rocco JW, Sidransky D, p16(MTS-1/CDKN2/INK4a) in cancer progression, Exp Cell Res, 2001, 264(1):42-55.
15. Kumamoto H, Kimi K, Ooya K, Detection of cell cycle-related factors in ameloblastomas, J Oral Pathol Med, 2001, 30(5): 309-315.
16. Artese L, Piattelli A, Rubini C, Goteri G, Perrotti V, Iezzi G, Piccirilli M, Carinci F, P16 expression in odontogenic tumors, Tumori, 2008, 94(5):718-723.
17. Suzuki H, Sugimura H, Kitayama Y, Uchiyama Y, Masumoto K, Tanaka H, Nagata T, Hashimoto K, Expression of p16INK4A in ameloblastoma: immunohistochemical and FISH analysis, Oral Med Pathol, 2010, 14(3):99-105.
18. Khojasteh A, Khodayari A, Rahimi F, Ghaderian MH, Jafarian M, Nayebi A, Akbarzadeh Najar R, Tabatabayipanah A, Jahangirnia A, Hypermethylation of p16 tumor-suppressor gene in ameloblastic carcinoma, ameloblastoma, and dental follicles, J Oral Maxillofac Surg, 2013, 71(1):62-65.
19. Brown DC, Gatter KC, Monoclonal antibody Ki-67: its use in histopathology, Histopathology, 1990, 17(6):489-503.
20. Scholzen T, Gerdes J, The Ki-67 protein: from the known and the unknown, J Cell Physiol, 2000, 182(3):311-322.
21. Kumamoto H, Detection of apoptosis-related factors and apoptotic cells in ameloblastomas: analysis by immunohistochemistry and an in situ DNA nick end-labelling method, J Oral Pathol Med, 1997, 26(9):419-425.
22. Li TJ, Browne RM, Matthews JB, Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in unicystic ameloblastoma, Histopathology, 1995, 26(3):219-228.
23. Ong'uti MN, Cruchley AT, Howells GL, Williams DM, Ki-67 antigen in ameloblastomas: correlation with clinical and histological parameters in 54 cases from Kenya, Int J Oral Maxillofac Surg, 1997, 26(5):376-379.
24. Kim J, Yook JI, Immunohistochemical study on proliferating cell nuclear antigen expression in ameloblastomas, Eur J Cancer B Oral Oncol, 1994, 30B(2):126-131.
25. Piatelli A, Fioroni M, Santinelli A, Rubini C, Expression of proliferating cell nuclear antigen in ameloblastomas and odontogenic cysts, Oral Oncol, 1998, 34(5):408-412.
26. Rizzardi C, Leocata P, Ventura L, Zweyer M, Brollo A, Schneider M, Melato M, Apoptosis-related factors (TRAIL, DR4, DR5, DcR1, DcR2, apoptotic cells) and proliferative activity in ameloblastomas, Anticancer Res, 2009, 29(4):1137-1142.
27. Florescu A, Simionescu C, Ciurea R, Pitru A, P53, Bcl-2 and Ki67 immunoexpression in follicular solid ameloblastomas, Rom J Morphol Embryol, 2012, 53(1):105-109.
28. Meer S, Galpin JS, Altini M, Coleman H, Ali H, Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2003, 95(2):213-221.
29. Rosenstein T, Pogrel MA, Smith RA, Regezi JA, Cystic ameloblastoma -behavior and treatment of 21 cases, J Oral Maxillofac Surg, 2001, 59(11):1311-1316; discussion 1316-1318.
30. Abdel-Aziz A, Amin MM, EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence, Diagn Pathol, 2012, 7:14.
31. Hirayama T, Hamada T, Hasui K, Semba I, Murata F, Sugihara K, Immunohistochemical analysis of cell proliferation and suppression of ameloblastoma with special reference to plexiform and follicular ameloblastoma, Acta Histochem Cytochem, 2004, 37(6):391-398.